This is unpublished
News

FDA Lifts Ban on Sending Mifepristone by Mail

January 27, 2022
Pinned
Back to top

Dr. Emily Godfrey, Associate Professor of ObGyn, was recently quoted in a Prevention article about the recent FDA decision to lift its existing ban on sending Mifepristone in the mail. Dr. Godfrey stated “Mifepristone is a really important medication not only for people who are seeking pregnancy termination, but also for people who are seeking miscarriage management.”. Read the article at this link.

News Categories

Recent News

3 weeks 3 days ago
MFM Fellow Allen Ghareeb to attend UC San Diego Fellowship i…
2 months 1 week ago
New blood test could help predict preeclampsia in pregnant p…
2 months 3 weeks ago
This Week in OBGYN | April 8, 2025